NCT01606059View on ClinicalTrials.gov

Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

DW-0920

Dosage form: Extended release tablet Dosage: 2 tablets

DRUG

DW-0919

Dosage form: Extended release tablet Dosage: 1 tablet

Trial Locations (1)

Unknown

Chungnam National University Hospital, Daejeon

Sponsors
All Listed Sponsors
collaborator

Chungnam National University Hospital

OTHER

lead

Daewon Pharmaceutical Co., Ltd.

INDUSTRY